Profitability Ratios
| Ratio |
Value |
| GP Margin |
75.1% |
| EBIT Margin |
8.2% |
| EBITDA Margin |
15.2% |
| Operating Margin |
14.2% |
| Pretax Margin |
-0.6% |
| Cont. Ops Margin |
-1.9% |
| Net Margin |
-1.9% |
| Bottom Line Margin |
-1.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.20 |
| Quick Ratio |
2.06 |
| Solvency Ratio |
0.040 |
| Cash Ratio |
0.76 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
4.90 |
| Forward PEG |
4.90 |
| Price/Book |
34.35 |
| Price/Sales |
6.61 |
| Price/FCF |
42.12 |
| Price/Op Cash Flow |
41.06 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.6308 |
| Debt/Equity |
4.8045 |
| Debt/Capital |
0.8277 |
| Long-Term Debt/Capital |
0.8226 |
| Financial Leverage |
7.62 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.55 |
| Operating Cash Flow Ratio |
0.455 |
| Operating Cash Flow/Sales |
16.1% |
| Free Cash Flow/Operating Cash Flow |
97.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.51 |
| Interest Coverage |
1.5967 |
| Short-Term Operating Cash Flow Coverage |
49.45 |
| Operating Cash Flow Coverage |
0.17 |
| Capital Expenditure Coverage |
39.80 |
| Dividend + Capital Expenditure Coverage |
39.80 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
7.41 |
| EPS |
-0.140 |
| Debt/Share |
7.5123 |
| Cash/Share |
1.98 |
| Book Value/Share |
1.42 |
| Tangible BV/Share |
-3.36 |
| Equity/Share |
1.43 |
| Operating Cash Flow/Share |
1.193 |
| Capital Expenditure/Share |
0.030 |
| FCF/Share |
1.163 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
2.981 |
| Earnings Before Tax/EBIT |
-0.045 |
| Price/Fair Value |
34.35 |
| Debt/Market Cap |
0.1355 |
| Effective Tax Rate |
-198.1% |
| Enterprise Value Multiple |
47.88 |
HROW - Harrow Health, Inc.